UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024141
Receipt number R000027795
Scientific Title The diagnosis of asymptomatic deep venous thrombosis by D-dimer in patients with recurrent gynecologic cancer.
Date of disclosure of the study information 2016/09/23
Last modified on 2021/03/28 18:17:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The diagnosis of asymptomatic deep venous thrombosis by D-dimer in patients with recurrent gynecologic cancer.

Acronym

D-diRec study

Scientific Title

The diagnosis of asymptomatic deep venous thrombosis by D-dimer in patients with recurrent gynecologic cancer.

Scientific Title:Acronym

D-diRec study

Region

Japan


Condition

Condition

Ovarian cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the application of periodic measurement of D-dimer to detect asymptomatic DVT in posttreatment patients with epithelial ovarian cancer.

Basic objectives2

Others

Basic objectives -Others

To assess the prevalence rate of DVT in recurrent ovarian cancer.
To assess the efficacy of D-dimer, CRP, or blood test to detect DVT.
To assess the efficacy of D-dimer to detect recurrent ovarian cancer.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

NPV,PPV,sensitivity,and specificity of D-dimer value to detect DVT

Key secondary outcomes

The prevalence rate of DVT in recurrent ovarian cancer.
NPV,PPV,sensitivity,and specificity and specificity of white blood cell count, neutrophil count, platelet count, and serum CRP value to detect DVT.
Tendency of D-dimer before clinical recurrence.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Measurement of D-dimer, blood cell count, neutrophil count, platelet count, serum CRP value.
Ultra-sonography of deep vein of leg (if D-dimer>1.5mg/mL )
Chest CT scan (if pulmonary thromboembolic disease was suspected)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Posttreatment women with epithelial ovarian cancer.

Key exclusion criteria

Patients with recurrent ovarian cancer.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Shoji
Middle name
Last name Nagao

Organization

Hyogo Cancer Center

Division name

Gynecologic Oncology

Zip code

673-8558

Address

13-70Kitaoji-cho, Akashi-city

TEL

078-929-1151

Email

nagao@hp.pref.hyogo.jp


Public contact

Name of contact person

1st name Shoji
Middle name
Last name Nagao

Organization

Hyogo Cancer Center

Division name

Gynecologic Oncology

Zip code

673-8558

Address

13-70Kitaoji-cho, Akashi-city

TEL

078-929-1151

Homepage URL


Email

nagao@hp.pref.hyogo.jp


Sponsor or person

Institute

Hyogo Cancer Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo Cancer Center IRB

Address

13-70Kitaoji-cho, Akashi-city

Tel

078-929-1151

Email

rinsyoshikenkanri3@hyogo-cc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 06 Month 12 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 23 Day

Last modified on

2021 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027795


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name